Insider Selling: Agilent Technologies (NYSE:A) Director Sells $95,974.92 in Stock

Agilent Technologies, Inc. (NYSE:A) Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Agilent Technologies Stock Down 1.4%

Shares of NYSE:A traded down $2.06 during trading on Wednesday, hitting $144.79. The stock had a trading volume of 1,843,878 shares, compared to its average volume of 2,247,818. The company has a market capitalization of $40.82 billion, a PE ratio of 28.50, a PEG ratio of 2.30 and a beta of 1.24. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. The firm’s fifty day moving average is $142.90 and its 200 day moving average is $128.22. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $163.75.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Core Wealth Advisors LLC acquired a new position in Agilent Technologies in the 4th quarter worth approximately $26,000. SHP Wealth Management purchased a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $26,000. Navalign LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter worth approximately $27,000. Cedar Mountain Advisors LLC acquired a new stake in shares of Agilent Technologies in the first quarter worth approximately $27,000. Finally, Markowski Investments purchased a new stake in shares of Agilent Technologies during the second quarter worth approximately $27,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. UBS Group started coverage on Agilent Technologies in a research note on Wednesday. They issued a “neutral” rating and a $165.00 price objective on the stock. TD Cowen upped their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday, August 27th. Jefferies Financial Group began coverage on shares of Agilent Technologies in a research report on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Morgan Stanley raised their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Finally, Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.